Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials.

Becker, Jan Ulrich; Seron, Daniel; Rabant, Marion; Roufosse, Candice; Naesens, Maarten

Becker, Jan Ulrich; Seron, Daniel; Rabant, Marion; Roufosse, Candice; Naesens, Maarten.

Afiliação

Becker JU; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Seron D; Department of Nephrology and Kidney Transplantation, Vall d'Hebrón University Hospital, Barcelona, Spain.
Rabant M; Department of Pathology, Hôpital Necker-Enfants Malades, Paris, France.
Roufosse C; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Naesens M; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Transpl Int ; 35: 10141, 2022.

Article em En | MEDLINE | ID: mdl-35669978

Assuntos

Transplante de Rim; Anticorpos; Biópsia; Rejeição de Enxerto/etiologia; Humanos; Rim/patologia; Linfócitos T

Palavras-chave

T cell-mediated rejection; antibody-mediated rejection; biopsy; borderline changes; kidney transplantation outcome; subclinical rejection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Etiology_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google